Viewing Study NCT00654758


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2026-04-23 @ 4:01 PM
Study NCT ID: NCT00654758
Status: COMPLETED
Last Update Posted: 2017-11-21
First Post: 2008-04-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None carcinoma View
None chemotherapy View
None monoclonal antibody therapy View
None anti-angiogenesis View